key: cord-0702028-brxw7eat authors: Bidar, Frank; Hamada, Sarah; Gossez, Morgane; Coudereau, Remy; Lopez, Jonathan; Cazalis, Marie-Angelique; Tardiveau, Claire; Brengel-Pesce, Karen; Mommert, Marine; Buisson, Marielle; Conti, Filippo; Rimmelé, Thomas; Lukaszewicz, Anne-Claire; Argaud, Laurent; Cour, Martin; Monneret, Guillaume; Venet, Fabienne title: Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients date: 2022-04-01 journal: Ann Intensive Care DOI: 10.1186/s13613-022-01007-7 sha: d5778f2e977391641b6cfb787d225d14054d1035 doc_id: 702028 cord_uid: brxw7eat nan In the original publication of the article [1] , the legends of x-and y-axis of panel a in Fig. 1 was inadvertently omitted. Figure 1 should have appeared as shown in this correction (Fig. 1) . The original article has been corrected. The original article can be found online at https:// doi. org/ 10. 1186/ s13613-022-00982-1. or down-regulated (right diagram, n = 48) genes between patients and HV are showed. c Ingenuity Pathway Analysis was applied on the list of differentially expressed genes at D0 and D20. Heatmaps of Log 10 P-value (from white indicating the absence of significance to dark red indicating a strong significance) and Z-score (from orange indicating a down-regulation to purple indicating an up-regulation) for pathways related to T cell activation at D0 and D20 are presented Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients, for the RICO study group Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations